Based on these survival-related genes, the five-gene signature (SLCO4C1, MAGEA1, POU4F1, IZUMO2, and NOVA1) was developed as a prognostic prediction biomarker for CRC (Supplementary Figure 5). The gene discussed is POU4F1; the disease is colorectal carcinoma.